MEDICINES CO (MDCO) Stock Price & Overview
NASDAQ:MDCO
Current stock price
The current stock price of MDCO is 84.9 null. Today MDCO is down by -0.07%. In the past month the price increased by 0.99%. In the past year, price increased by 356.21%.
MDCO Key Statistics
- Market Cap
- 6.768B
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.98
- Dividend Yield
- N/A
MDCO Stock Performance
MDCO Stock Chart
MDCO Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to MDCO. When comparing the yearly performance of all stocks, MDCO is one of the better performing stocks in the market, outperforming 99.5% of all stocks.
MDCO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MDCO. Both the profitability and financial health of MDCO have multiple concerns.
MDCO Earnings
MDCO Forecast & Estimates
MDCO Financial Highlights
Over the last trailing twelve months MDCO reported a non-GAAP Earnings per Share(EPS) of -2.98. The EPS increased by 32.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.35% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
MDCO Ownership
About MDCO
Company Profile
The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.
Company Info
MEDICINES CO
8 SYLVAN WAY
PARSIPPANY NJ 07054
CEO: Mark Timney
Phone: 973-290-6000
MEDICINES CO / MDCO FAQ
Can you describe the business of MEDICINES CO?
The Medicines Company is a biopharmaceutical company driven by an overriding purpose-to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in two critical therapeutic areas: serious infectious disease care and cardiovascular care. The Company's mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in serious infectious disease care and cardiovascular care.
Can you provide the latest stock price for MEDICINES CO?
The current stock price of MDCO is 84.9 null. The price decreased by -0.07% in the last trading session.
Does MDCO stock pay dividends?
MDCO does not pay a dividend.
What is the ChartMill technical and fundamental rating of MDCO stock?
MDCO has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for MDCO stock?
MEDICINES CO (MDCO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.98).
Should I buy MDCO stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MDCO.